108.0K XNAS Volume
XNAS 28 Mar, 2025 11:26 AM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Christopher M. Murphy | Chief Financial & Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 30,000 | 30,000 | - | - | Restricted Stock Unit | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 50,000 | 50,000 | - | - | Restricted Stock Unit | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 16,500 | 16,500 | - | - | Restricted Stock Unit | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 132,000 | 132,000 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 12,500 | 12,500 | - | - | Restricted Stock Unit | |
| Christopher M. Murphy | Chief Financial & Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 17,500 | 17,500 | - | - | Restricted Stock Unit | |
| Christopher M. Murphy | Chief Financial & Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 92,000 | 92,000 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 11,500 | 11,500 | - | - | Restricted Stock Unit | |
| Dennis Dean | Chief Nonclinical Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 11,500 | 11,500 | - | - | Restricted Stock Unit | |
| Dennis Dean | Chief Nonclinical Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 92,000 | 92,000 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 08 Nov 2024 | 2,117 | 0 | - | 15 | 31,755 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 08 Nov 2024 | 2,117 | 2,117 | - | 4.2 | 8,891 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 2,117 | 368,918 | - | - | Employee Option Grant (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 28 Oct 2024 | 2,673 | 2,673 | - | 4.2 | 11,227 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Oct 2024 | 2,673 | 371,035 | - | - | Employee Option Grant (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 28 Oct 2024 | 2,673 | 0 | - | 15 | 40,095 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 19 Sep 2024 | 4,790 | 0 | - | 15 | 71,850 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 19 Sep 2024 | 4,790 | 4,790 | - | 4.2 | 20,118 | Common Stock |
| Edward R. Conner | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Sep 2024 | 4,790 | 373,708 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 18 Sep 2024 | 503 | 0 | - | 14 | 7,042 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 18 Sep 2024 | 503 | 503 | - | 4.2 | 2,113 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 9,497 | 155,962 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Sep 2024 | 503 | 165,459 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.29 per share. | 18 Sep 2024 | 9,497 | 0 | - | 14.3 | 135,685 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 18 Sep 2024 | 9,497 | 9,497 | - | 4.2 | 39,887 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 26 Jun 2024 | 10,000 | 10,000 | - | 4.2 | 42,000 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Jun 2024 | 10,000 | 165,962 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 12.46 per share. | 26 Jun 2024 | 10,000 | 0 | - | 12.5 | 124,569 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 494 | 16,294 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Sale of securities on an exchange or to another person at price $ 14.17 per share. | 07 Jun 2024 | 494 | 0 | - | 14.2 | 7,000 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Grant, award, or other acquisition of securities at price $ 4.20 per share. | 07 Jun 2024 | 494 | 494 | - | 4.2 | 2,075 | Common Stock |
| Mark T. Iwicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| David P. Bonita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Michael Gladstone | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| H. Martin Seidel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Director Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 20 May 2024 | 1,042 | 0 | - | 14 | 14,588 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Grant, award, or other acquisition of securities at price $ 4.30 per share. | 20 May 2024 | 1,042 | 1,042 | - | 4.3 | 4,481 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 1,042 | 32,292 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 6,912 | 16,788 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 16,666 | 33,334 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) | |
| Jennifer Dittman | Chief Development Oper Officer | Sale of securities on an exchange or to another person at price $ 14.04 per share. | 16 May 2024 | 23,578 | 0 | - | 14.0 | 331,066 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Grant, award, or other acquisition of securities at price $ 4.20 per share. | 16 May 2024 | 6,912 | 23,578 | - | 4.2 | 29,030 | Common Stock |
| Jennifer Dittman | Chief Development Oper Officer | Grant, award, or other acquisition of securities at price $ 4.30 per share. | 16 May 2024 | 16,666 | 16,666 | - | 4.3 | 71,664 | Common Stock |
| Dennis Dean | Chief Nonclinical Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 210,000 | 210,000 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 May 2024 | 20,222 | 433,854 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.18 per share. | 09 May 2024 | 20,222 | 1,218,836 | - | 12.2 | 246,300 | Common Stock |
| Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 09 May 2024 | 20,222 | 1,239,058 | - | 4.2 | 84,932 | Common Stock |
| Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 11 Apr 2024 | 13,558 | 1,232,394 | - | 4.2 | 56,944 | Common Stock |
| Natalie C. Holles | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Apr 2024 | 13,558 | 454,076 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Sale of securities on an exchange or to another person at price $ 12.19 per share. | 11 Apr 2024 | 13,558 | 1,218,836 | - | 12.2 | 165,214 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 1,107 | 175,962 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 04 Apr 2024 | 1,107 | 1,107 | - | 4.2 | 4,649 | Common Stock |
| Julie Person | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 10.00 per share. | 04 Apr 2024 | 1,107 | 0 | - | 10 | 11,070 | Common Stock |
| Geoffrey McDonough | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Julie Person | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 116,000 | 116,000 | - | - | Employee Option Grant (right to buy) | |
| Christopher Murphy M. | Chief Financial & Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 410,000 | 410,000 | - | - | Employee Option Grant (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 133,000 | 133,000 | - | - | Employee Option Grant (right to buy) | |
| Natalie Holles C. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 396,000 | 396,000 | - | - | Employee Option Grant (right to buy) | |
| C. Holles Natalie | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 396,000 | 396,000 | - | - | Employee Option Grant (right to buy) | |
| Person Julie | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 05 Dec 2023 | 12,863 | 12,863 | - | 4.2 | 54,025 | Common Stock |
| Conner R. Edward | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 4,790 | 378,498 | - | - | Employee Option Grant (right to buy) | |
| Person Julie | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 05 Dec 2023 | 12,863 | 0 | - | 10.3 | 132,484 | Common Stock |
| Person Julie | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Dec 2023 | 12,863 | 67,137 | - | - | Employee Option Grant (right to buy) | |
| Conner R. Edward | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.20 per share. | 05 Dec 2023 | 4,790 | 4,790 | - | 4.2 | 20,118 | Common Stock |
| Edward Conner R. | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 05 Dec 2023 | 4,790 | 0 | - | 10.0 | 48,062 | Common Stock |
| Mark T. Iwicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| H. Martin Seidel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,250 | 16,250 | - | - | Stock Option (right to buy) | |
| Mark T. Iwicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 35,413 | 35,413 | - | - | Employee Stock Option (right to buy) | |
| Mark T. Iwicki | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 35,413 | 0 | - | - | Employee Stock Option (right to buy) | |
| Mark T. Iwicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Mark T. Iwicki | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Robert J. Perez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Robert J. Perez | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 76,582 | 76,582 | - | - | Employee Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 76,582 | 0 | - | - | Employee Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| David P. Bonita | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 205,000 | 205,000 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 360,000 | 360,000 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 467,634 | 0 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 467,634 | 467,634 | - | - | Employee Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 205,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 383,288 | 383,288 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 137,000 | 137,000 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 383,288 | 0 | - | - | Employee Stock Option (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Robert Ho | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 367,955 | 0 | - | - | Employee Stock Option (right to buy) | |
| Robert Ho | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 136,000 | 136,000 | - | - | Employee Stock Option (right to buy) | |
| Robert Ho | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Robert Ho | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Robert Ho | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 367,955 | 367,955 | - | - | Employee Stock Option (right to buy) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Michael Gladstone | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | Chief Administrative Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 80,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 177,069 | 177,069 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 119,000 | 119,000 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
| Julie Person | Chief Administrative Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 177,069 | 0 | - | - | Employee Stock Option (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 95,000 | - | - | Employee Stock Option (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 95,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 309,871 | 309,871 | - | - | Employee Stock Option (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 309,871 | 0 | - | - | Employee Stock Option (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 132,000 | 132,000 | - | - | Employee Stock Option (right to buy) | |
| H. Martin Seidel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 0 | - | - | Employee Stock Option (right to buy) | |
| H. Martin Seidel | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 06 Mar 2023 | 6,640 | 0 | - | - | Employee Stock Option (right to buy) | |
| H. Martin Seidel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 6,640 | 6,640 | - | - | Employee Stock Option (right to buy) | |
| H. Martin Seidel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 13,667 | 13,667 | - | - | Employee Stock Option (right to buy) | |
| Mark T. Iwicki | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Robert J. Perez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Thomas M. Soloway | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| David P. Bonita | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Shao-Lee Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| H. Martin Seidel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2022 | 13,667 | 13,667 | - | - | Stock Option (right to buy) | |
| Natalie C. Holles | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 205,000 | 205,000 | - | - | Employee Option Grant (right to buy) | |
| Edward R. Conner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 95,000 | 95,000 | - | - | Employee Option Grant (right to buy) | |
| Robert Ho | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 95,000 | 95,000 | - | - | Employee Option Grant (right to buy) | |
| Julie Person | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 80,000 | 80,000 | - | - | Employee Option Grant (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 95,000 | 95,000 | - | - | Employee Option Grant (right to buy) | |
| Adrian S. Ray | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2022 | 95,000 | 95,000 | - | - | Employee Option Grant (right to buy) | |
| David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 5,479,071 | 5,479,071 | - | - | Common Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 1,342,065 | 0 | - | - | Series B Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 2,441,407 | 0 | - | - | Series A-3 Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | 19 Sep 2022 | 8,593,750 | 0 | - | - | Series A-2 Preferred Stock | ||
| David P. Bonita | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.00 per share. | 19 Sep 2022 | 300,000 | 5,779,071 | - | 17 | 5,100,000 | Common Stock |